|
80
|
271
|
3fzsA |
Crystal structure of pyk2 complexed with birb796 |
|
85
|
271
|
3fztA |
Crystal structure of pyk2 complexed with pf-4618433 |
|
81
|
272
|
3fzoA |
Crystal structure of pyk2-apo, proline-rich tyrosine kinase |
|
90
|
317
|
3fhrA |
High resolution crystal structure of mitogen-activated protein kinase-activated protein kinase 3 (mk3)-inhibitor complex |
|
81
|
306
|
3f82A |
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with n-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide |
|
78
|
285
|
3f69A |
Crystal structure of the mycobacterium tuberculosis pknb mutant kinase domain in complex with kt5720 |
|
85
|
307
|
3f5pA |
Complex structure of insulin-like growth factor receptor and 3-cyanoquinoline inhibitor |
|
110
|
349
|
3flsA |
P38 kinase crystal structure in complex with 6-(2,4-difluoro-phenoxy)-2-((r)-2-methanesulfonyl-1-methyl-ethylamino)-8-methyl-8h-pyrido[2,3-d]pyrimidin-7-one |
|
112
|
349
|
3fklA |
P38 kinase crystal structure in complex with ro9552 |
|
101
|
357
|
3fi3A |
Crystal structure of jnk3 with indazole inhibitor, sr-3737 |
|
112
|
329
|
3fmdA |
Crystal structure of human haspin with an isoquinoline ligand |
|
93
|
298
|
3f66A |
Human c-met kinase in complex with quinoxaline inhibitor |
|
113
|
349
|
3fmmA |
P38 kinase crystal structure in complex with ro6226 |
|
108
|
349
|
3fl4A |
P38 kinase crystal structure in complex with ro5634 |
|
105
|
349
|
3fi4A |
P38 kinase crystal structure in complex with ro4499 |
|
79
|
264
|
3f9nA |
Crystal structure of chk1 kinase in complex with inhibitor 38 |
|
94
|
288
|
3f7wA |
Crystal structure of putative fructosamine-3-kinase (yp_290396.1) from thermobifida fusca yx-er1 at 1.85 a resolution |
|
84
|
298
|
3f5xA |
Cdk-2-cyclin complex with indazole inhibitor 9 bound at its active site |
|
113
|
349
|
3fmhA |
P38 kinase crystal structure in complex with 6-(2,4-difluoro-phenoxy)-8-methyl-2-((r)-1-methyl-2-tetrazol-2-yl-ethylamino)-8h-pyrido[2,3-d]pyrimidin-7-one |
|
88
|
293
|
3f5gA |
Crystal structure of death associated protein kinase in complex with adp and mg2+ |
|
104
|
348
|
3fc1X |
Crystal structure of p38 kinase bound to pyrimido-pyridazinone inhibitor |
|
98
|
349
|
3f88A |
Glycogen synthase kinase 3beta inhibitor complex |
|
108
|
348
|
3fkoA |
P38 kinase crystal structure in complex with ro3668 |
|
107
|
338
|
3fhiA |
Crystal structure of a complex between the catalytic and regulatory (ri{alpha}) subunits of pka |
|
84
|
269
|
3fdnA |
Structure-based drug design of novel aurora kinase a inhibitors: structure basis for potency and specificity |
|
81
|
279
|
3f6xA |
C-src kinase domain in complex with small molecule inhibitor |
|
110
|
349
|
3fmkA |
P38 kinase crystal structure in complex with 6-(2,4-difluoro-phenoxy)-8-methyl-2-((s)-1-methyl-2-tetrazol-2-yl-ethylamino)-8h-pyrido[2,3-d]pyrimidin-7-one |
|
82
|
277
|
3f3uA |
Kinase domain of csrc in complex with inhibitor rl37 (type iii) |
|
108
|
336
|
3fjqE |
Crystal structure of camp-dependent protein kinase catalytic subunit alpha in complex with peptide inhibitor pki alpha (6-25) |
|
82
|
293
|
3fc2A |
Plk1 in complex with bi6727 |
|
110
|
350
|
3flnC |
P38 kinase crystal structure in complex with r1487 |
|
108
|
349
|
3fmlA |
P38 kinase crystal structure in complex with ro6224 |
|
80
|
277
|
3f3tA |
Kinase domain of csrc in complex with inhibitor rl38 (type iii) |
|
112
|
418
|
3fbvA |
Crystal structure of the oligomer formed by the kinase-ribonuclease domain of ire1 |
|
98
|
350
|
3f7zA |
X-ray co-crystal structure of glycogen synthase kinase 3beta in complex with an inhibitor |
|
81
|
290
|
3f61A |
Crystal structure of m. tuberculosis pknb leu33asp/val222asp double mutant in complex with adp |
|
67
|
288
|
3fmeA |
Crystal structure of human mitogen-activated protein kinase kinase 6 (mek6) activated mutant (s207d, t211d) |
|
87
|
272
|
3f3zA |
Crystal structure of cryptosporidium parvum calcium dependent protein kinase cgd7_1840 in presence of indirubin e804 |
|
102
|
317
|
3fe3A |
Crystal structure of the kinase mark3/par-1: t211a-s215a double mutant |
|
108
|
349
|
3fmnA |
P38 kinase crystal structure in complex with ro2530 |
|
105
|
325
|
3fl5A |
Protein kinase ck2 in complex with the inhibitor quinalizarin |
|
112
|
349
|
3fknA |
P38 kinase crystal structure in complex with ro7125 |
|
100
|
345
|
3fi2A |
Crystal structure of jnk3 with amino-pyrazole inhibitor, sr-3451 |
|
111
|
349
|
3flyA |
P38 kinase crystal structure in complex with 6-(2,4-difluoro-phenoxy)-2-isopropylamino-8-methyl-8h-pyrido[2,3-d]pyrimidin-7-one |
|
81
|
277
|
3f3vA |
Kinase domain of csrc in complex with inhibitor rl45 (type ii) |
|
107
|
349
|
3fmjA |
P38 kinase crystal structure in complex with 4-(5-methyl-3-phenyl-isoxazol-4-yl)-pyrimidin-2-ylamine |
|
93
|
293
|
3f5uA |
Crystal structure of the death associated protein kinase in complex with amppnp and mg2+ |
|
109
|
349
|
3flzA |
P38 kinase crystal structure in complex with 8-methyl-6-phenoxy-2-(tetrahydro-pyran-4-ylamino)-8h-pyrido[2,3-d]pyrimidin-7-one |
|
112
|
328
|
3f2nA |
Crystal structure of human haspin with an imidazo-pyridazine ligand |
|
86
|
330
|
3faaA |
Crystal structure of tgfbri complexed with a 2-aminoimidazole inhibitor |
